This study investigates the impact of various
factors on the lifespan and diagnostic time of HIV/AIDS patients using advanced
statistical techniques. The Power Chris-Jerry (PCJ) distribution is applied to
model CD4 counts of patients, and the goodness-of-fit test confirms a strong
fit with a p-value of 0.6196. The PCJ distribution is found to be the best fit
based on information criteria (AIC and BIC) with the smallest negative
log-likelihood, AIC, and BIC values. The study uses datasets from St. Luke
hospital Uyo, Nigeria, containing HIV/AIDS diagnosis date, age, CD4 count,
gender, and opportunistic infection dates. Multiple linear regression is
employed to analyze the relationship between these variables and HIV/AIDS
diagnostic time. The results indicate that age, CD4 count, and opportunistic
infection significantly impact the diagnostic time, while gender shows a
nonsignificant relationship. The F-test confirms the model's overall
significance, indicating the factors are good predictors of HIV/AIDS diagnostic
time. The R-squared value of approximately 72% suggests that administering
antiretroviral therapy (ART) can improve diagnostic time by suppressing the
virus and protecting the immune system. Cox proportional hazard modeling is
used to examine the effects of predictor variables on patient survival time.
Age and CD4 count are not significant factors in the hazard of HIV/AIDS
diagnostic time, while opportunistic infection is a significant predictor with
a decreasing effect on the hazard rate. Gender shows a strong but nonsignificant
relationship with decreased risk of death. To address the violation of the
assumption of proportional hazard, the study employs an assumption-free
alternative, Aalen’s model.
In the Aalen model, all predictor variables except age and gender are statistically
significant in relation to HIV/AIDS diagnostic time. The findings provide
valuable insights into the factors influencing diagnostic time and survival of
HIV/AIDS patients, which can inform interventions aimed at reducing
transmission and improving early diagnosis and treatment. The Power Chris-Jerry
distribution proves to be a suitable fit for modeling CD4 counts, while
multiple linear regression and survival analysis techniques provide insights
into the relationships between predictor variables and diagnostic time. These
results contribute to the understanding of HIV/AIDS patient outcomes and can
guide public health interventions to enhance early detection, treatment, and
care.
References
[1]
Marks, G., Crepaz, N. and Janssen, R.S. (2006) Estimating Sexual Transmission of HIV from Persons Aware and Unaware That They Are Infected with the Virus in the USA. AIDS, 20, 1447-1450.
https://doi.org/10.1097/01.aids.0000233579.79714.8d
[2]
Mugavero, M.J., Amico, K.R., Horn, T. and Thompson, M.A. (2013) The State of Engagement in HIV Care in the United States: From Cascade to Continuum to Control. Clinical Infectious Diseases, 57, 1164-1171.
https://doi.org/10.1093/cid/cit420
[3]
May, M., Gompels, M. and Delpech, V. (2011) Impact of Late Diagnosis and Treatment on Life Expectancy in People with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. The BMJ, 343, d6016. https://doi.org/10.1136/bmj.d6016
[4]
Sobrino-Vegas, P., Rodríguez-Urrego, J. and Berenguer, J. (2001) Delayed Diagnosis of HIV Infection in Spain: Missed Opportunities for Optimal Intervention. Journal of Acquired Immune Deficiency Syndromes, 26, 513-520.
[5]
Palella Jr, F.J., Deloria-Knoll, M. and Chmiel, J.S. (2003) Survival Benefit of Initiating Antiretroviral Therapy in HIV-Infected Persons in Different CD4+ Cell Strata. Annals of Internal Medicine, 138, 620-626.
https://doi.org/10.7326/0003-4819-138-8-200304150-00007
[6]
Pathai, S., Bajillan, H., Landay, A.L. and High, K.P. (2014) Is HIV a Model of Accelerated or Accentuated Aging? The Journals of Gerontology: Series A, 69, 833-842.
https://doi.org/10.1093/gerona/glt168
[7]
Lawn, S.D., Butera, S.T. and Folks, T.M. (2001) Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection. Clinical Microbiology Reviews, 14, 753-777.
https://doi.org/10.1128/CMR.14.4.753-777.2001
[8]
Kuller, L.H., Tracy, R. and Belloso, W. (2008) Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection. PLOS Medicine, 5, e203.
https://doi.org/10.1371/journal.pmed.0050203
[9]
Nacher, M., Huber, F., Adriouch, L., Djossou, F., Adenis, A. and Couppie, P. (2018) Temporal Trend of the Proportion of Patients Presenting with Advanced HIV in French Guiana: Stuck on the Asymptote? BMC Research Notes, 11, Article No. 831.
[10]
Coffin, J.M. (1999) Molecular Biology of HIV. In: Crandall, K.A., Ed., The Evolution of HIV, Johns Hopkins University Press, Baltimore, 3-40.
[11]
Udofia, E.M., Umeh, E.U. and Onyekwere, C.K. (2021) Modeling of Survival of HIV Patients by Stages of Immune Suppression and Opportunisic Infections. American Journal of Theoretical and Applied Statistics, 10, 233-242.
https://doi.org/10.11648/j.ajtas.20211006.12
[12]
Jin, M., Yang, Z., Li, J., Liu, X. and Wu, Z. (2022) Factors Influencing Survival Status of HIV/AIDS after HAART in Huzhou City, Eastern China. Canadian Journal of Infectious Diseases and Medical Microbiology, 2022, Article ID: 2787731.
https://doi.org/10.1155/2022/2787731
[13]
Shanker, R. (2015) Shanker Distribution and Its Applications. International Journal of Statistics and Applications, 5, 338-348.
https://doi.org/10.15406/bbij.2016.03.00075
[14]
Ghitany, M.E., Al-Mutairi, D.K., Balakrishnan, N. and Al-Enezi, L.J. (2013) Power Lindley Distribution and Associated Inference. Computational Statistics & Data Analysis, 64, 20-33. https://doi.org/10.1016/j.csda.2013.02.026
[15]
Lindley, D.V. (1958) Fiducial Distributions and Bayes’ Theorem. Journal of the Royal Statistical Society: Series B (Methodological), 20, 102-107.
https://doi.org/10.1111/j.2517-6161.1958.tb00278.x
[16]
Shanker, R. and Shukl, K.K. (2017) Power Shanker Distribution and Its Application. Turkiye Klinikleri Journal of Biostatistics, 9, 175-187.
https://doi.org/10.5336/biostatic.2017-56601
[17]
Shukla, K.K. (2018) Prakaamy Distribution with Properties and Applications. Journal of Applied Quantitative Methods, 13, 30-38.
[18]
Shukla, K.K. and Shanker, R. (2020) Power Prakaamy Distribution and Its Applications. Journal of Computational & Theoretical Statistics, 7, 25-36.
[19]
Shanker, R. (2017) Akshaya Distribution and Its Application. American Journal of Mathematics and Statistics, 7, 51-59.
[20]
Rosa, L.A., Nurrohmah, S. and Fithriani, I. (2019) α Power Transformed Lindley Distribution. ICSA-International Conference on Statistics and Analytics 2019, Bogor, 2-3 August 2019, 130-142. https://doi.org/10.29244/icsa.2019.pp130-142
[21]
Onyekwere, C.K. and Obulezi, O.J. (2022) Chris-Jerry Distribution and Its Applications. Asian Journal of Probability and Statistics, 20, 16-30.
https://doi.org/10.9734/ajpas/2022/v20i130480
[22]
Abebe, B., Tesfay, M., Eyob, T. and Shanker, R. (2019) A Two-Parameter Power Rama Distribution with Properties and Applications. Biometrics and Biostatistics International Journal, 8, 6-11. https://doi.org/10.15406/bbij.2019.08.00262
[23]
Shanker, R. and Shukla, K.K. (2017) Power Shanker Distribution and Its Application. Turkiye Klinikleri Journal of Biostatistics, 9, 175-187.
https://doi.org/10.5336/biostatic.2017-56601